Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;9(1):e002217.
doi: 10.1136/bmjdrc-2021-002217.

Identification of candidate gene variants of monogenic diabetes using targeted panel sequencing in early onset diabetes patients

Affiliations

Identification of candidate gene variants of monogenic diabetes using targeted panel sequencing in early onset diabetes patients

Dong-Hwa Lee et al. BMJ Open Diabetes Res Care. 2021 Jun.

Abstract

Introduction: Monogenic diabetes is attributed to genetic variations in a single gene. Maturity-onset diabetes of the young (MODY) is the most common phenotype associated with monogenic diabetes, but is frequently misdiagnosed as either type 1 or type 2 diabetes. Increasing our basic understanding of genetic variations in MODY may help to improve the accuracy of providing the correct diagnosis and personalize subsequent treatment regimens in different racial populations. For this reason, this study was designed to identify nucleotide variants in early onset diabetes patients with clinically suspected MODY in a Korean population.

Research design and methods: Among 2908 Korean patients diagnosed with diabetes, we selected 40 patients who were diagnosed before 30 years old and were clinically suspected of MODY. Genetic testing was performed using a targeted gene sequencing panel that included 30 known monogenic diabetes genes. The pathogenicity of the identified variants was assessed according to the American College of Medical Genetics and Genomics and Association for Molecular Pathology (ACMG-AMP) guidelines.

Results: A total of six rare missense variants (p.Ala544Thr in HNF1A, p.Val601Ile and p.His103Tyr in ABCC8, p.Pro33Ala in PDX1, p.Gly18Glu in INS, and p.Arg164Gln in PAX4) in five distinct MODY genes were identified in five patients. In addition, a variant was identified in mitochondrial DNA at 3243A>G in one patient. The identified variants were either absent or detected at a rare frequency in the 1000 Genomes Project. These variants were classified as uncertain significance using the ACMG-AMP guidelines.

Conclusion: Using a targeted gene sequencing panel, we identified seven variants in either MODY genes or mitochondrial DNA using a Korean patient population with early onset diabetes who were clinically suspected of MODY. This genetic approach provides the ability to compare distinct populations of racial and ethnic groups to determine whether specific gene is involved in their diagnosis of MODY.

Keywords: diabetes mellitus; diagnostic techniques and procedures; genetics; human genetics; type 2.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
The spectrum of genetic variants in five MODY genes identified. Each note above represents a variant in this study. Each colored asterisk below represents a genetic mutation reported in ClinVar (red—putative loss off function, orange—missense, black—other). (A) ABCC8 gene. (B) PDX1 gene. (C) INS-IGF2 gene. (D) PAX4 gene. (E) HNF1A gene. Adapted from gnomAD (https://gnomad.broadinstitute.org/).

Similar articles

Cited by

References

    1. American Diabetes Association . 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020;43:S14–31. 10.2337/dc20-S002 - DOI - PubMed
    1. Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab 2008;4:200–13. 10.1038/ncpendmet0778 - DOI - PubMed
    1. Shepherd M, Shields B, Hammersley S, et al. . Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes. Diabetes Care 2016;39:1879–88. 10.2337/dc16-0645 - DOI - PMC - PubMed
    1. Kim SH. Maturity-Onset diabetes of the young: what do clinicians need to know? Diabetes Metab J 2015;39:468–77. 10.4093/dmj.2015.39.6.468 - DOI - PMC - PubMed
    1. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001;345:971–80. 10.1056/NEJMra002168 - DOI - PubMed

Publication types